Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-19, Stock:ABBV, The news for the past five days is as follows:
2020-06-12: NEWS1: AbbVie Recommends Shareholders Reject TRC Capital's &quot;Mini-Tender&quot; Offer.NEWS2: AbbVie Presents New Late-Breaking Data Showing SKYRIZI® (risankizumab-rzaa) Achieves Superior Rates of Complete Skin Clearance Versus COSENTYX® (secukinumab) at 52 Weeks.NEWS3: The Zacks Analyst Blog Highlights: AbbVie, Eagle Bancorp Montana, H&R Block, Mackinac Financial and Virtu Financial.NEWS4: 5 Defensive Stocks to Buy as Coronavirus Cases Rise Again.NEWS5: Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals.NEWS6: COVID-19 cases surge, officials issue warnings.NEWS7: Go Defensive to Beat Market Turbulence With These 4 Stocks.NEWS8: AbbVie Jumped Into The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?.
2020-06-15: NEWS1: Merck's Gardasil Gets FDA Approval for Head and Neck Cancers.NEWS2: Roche (RHHBY) Presents Positive Data on Venclexta at EHA 2020.NEWS3: FDA Approves JUVÉDERM® VOLUMA™ XC for Enhancement of the Chin Region.NEWS4: AbbVie to Showcase 27 Studies at the Virtual 2020 Annual Scientific Meeting of the American Headache Society.
2020-06-16: NEWS1: Why the Cannabis Sector May be Turning a New Leaf.
2020-06-17: NEWS1: AbbVie Declares Quarterly Dividend.NEWS2: Endometriosis: an invisible disease affecting half a million Canadians.NEWS3: U.K. trial sparks interest in dexamethasone’s potential as a treatment for severely ill COVID-19 patients.
2020-06-18: NEWS1: Buy These 4 Big Drugmakers to Keep Coronavirus Woes at Bay.NEWS2: RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis.NEWS3: Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101.

Answer: Rise